Metropolitan Life Insurance Company (MetLife)’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,143
Closed -$186K 2518
2022
Q4
$186K Buy
11,143
+239
+2% +$4.04K 0.01% 747
2022
Q3
$187K Hold
10,904
0.01% 698
2022
Q2
$85.5K Buy
10,904
+3,317
+44% +$28.5K ﹤0.01% 1152
2022
Q1
$84.1K Sell
7,587
-24,432
-76% -$274K ﹤0.01% 1310
2021
Q4
$563K Hold
32,019
0.01% 1345
2021
Q3
$648K Buy
32,019
+42
+0.1% +$1.08K 0.01% 1280
2021
Q2
$1.06M Buy
31,977
+10,057
+46% +$380K 0.01% 972
2021
Q1
$857K Sell
21,920
-946
-4% -$44.4K 0.01% 1070
2020
Q4
$998K Hold
22,866
0.01% 889
2020
Q3
$648K Buy
22,866
+16,091
+238% +$508K 0.01% 1029
2020
Q2
$246K Hold
6,775
﹤0.01% 1668
2020
Q1
$123K Buy
+6,775
New +$149K ﹤0.01% 1899

Metropolitan Life Insurance Company (MetLife)'s ONEM Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 11,143 shares — an estimated $186K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $1.06M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 11,143 1Life Healthcare shares in Q1 2023, an estimated $186K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s 1Life Healthcare position peaked at $1.06M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.